SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018671
Filing Date
2018-08-02
Accepted
2018-08-02 07:31:36
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20180630.htm 10-Q 1647977
2 EX-31.1 epzm-ex311_8.htm EX-31.1 8514
3 EX-31.2 epzm-ex312_6.htm EX-31.2 8478
4 EX-32.1 epzm-ex321_9.htm EX-32.1 6177
  Complete submission text file 0001564590-18-018671.txt   5523206

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20180630.xml EX-101.INS 1158207
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20180630.xsd EX-101.SCH 40347
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20180630_cal.xml EX-101.CAL 36457
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20180630_def.xml EX-101.DEF 126957
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20180630_lab.xml EX-101.LAB 311176
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20180630_pre.xml EX-101.PRE 222833
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 18986667
SIC: 2834 Pharmaceutical Preparations